Europa’s gluten-free, meal-replacement bars make appearance at ECRM show
SAN ANTONIO — “The View” co-host Elisabeth Hasselbeck aims to raise awareness around celiac disease, coupling her recently published book, "The G-Free Diet: A Gluten-Free Survival Guide," with a line of gluten-free, meal-replacement bars called Nogii in partnership with Europa Sports Products.
The Nogii line was presented to buyers attending ECRM Vitamin, Diet and Sports Nutrition here last week, and includes a Nogii kids’ bar that will begin shipping in March. The two adult gluten-free/protein-rich bars are available in peanut butter/chocolate (20 g of protein, 8 g of fat and 230 calories) and chocolate peanut butter caramel crisp (30 g of protein, 14 g of fat and 390 calories).
In addition to making mention of the Nogii line on “The View,” Hasselbeck also will be appearing at such events as NatExpoWest to promote the product.
New Extenze product on display at ECRM conference
SAN ANTONIO — Biotab Nutraceuticals last week showcased an Extenze line extension — an energy-shot delivery format — at the ECRM Vitamin, Diet and Sports Nutrition conference here.
The cherry-flavored shot retails for approximately $5.99 as a two-pack SKU.
Survey: Patients oppose PSE prescription mandate
WASHINGTON — As many as 71% of cough-cold sufferers in search of decongestant relief oppose a prescription requirement for pseudoephedrine, according to a survey commissioned by the Asthma and Allergy Foundation of America released Monday.
"Taking away patient freedom by requiring prescriptions for important over-the-counter medications is not a solution to the meth problem," stated Mike Tringale, VP external affairs at AAFA. "Based on our recent survey of allergy, asthma, cold-cough and flu patients, we recognize that timely access to these medicines is critical for people."
According to the findings in AAFA’s survey, two-thirds of respondents would support a law for nationwide electronic tracking of medication purchases and 64% would prefer an e-tracking law, rather than requiring a doctor’s prescription, to track and block sales of PSE that go over the legal limit.
When faced with the choice, 63% of asthma, allergy, cold, cough and flu sufferers said they agreed that the implementation of e-tracking would be the most effective way of preventing medication sales for illegal uses without penalizing those who truly need them. Only 18% indicated their belief that a doctor’s prescription would be the most effective control mechanism. The chief reasons patients in the survey preferred e-tracking include:
It is more effective and less burdensome than requiring prescriptions (66% support);
It doesn’t infringe on law-abiding citizens who want easy and immediate access to the OTC meds they need (49% opposed a prescription requirement for this reason);
E-tracking builds on the existing framework and law enforcement in states and regions (65% support);
It can be updated in real time (59% support); and
Health records remain private and protected (65% support).
The survey of 2,006 consumers who purchased nonprescription medicines for their condition was conducted by Harris Interactive and supported by a grant from the Consumer Healthcare Products Association.
The survey report is available online at AAFA.org/pse.